Abcellera Biologics Inc (8QQ)

Currency in EUR
4.36
+0.12(+2.74%)
Delayed Data·
8QQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.244.36
52 wk Range
1.724.95
Key Statistics
Bid/Ask
4.27 / 4.33
Prev. Close
4.24
Open
4.24
Day's Range
4.24-4.36
52 wk Range
1.72-4.95
Volume
1.9K
Average Volume (3m)
22.39K
1-Year Change
45.8%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
8QQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Abcellera Biologics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Abcellera Biologics Inc Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Compare 8QQ to Peers and Sector

Metrics to compare
8QQ
Peers
Sector
Relationship
P/E Ratio
0.0x−2.9x−0.5x
PEG Ratio
0.000.090.00
Price/Book
0.0x1.1x2.6x
Price / LTM Sales
0.0x2.1x3.2x
Upside (Analyst Target)
0.0%38.2%41.2%
Fair Value Upside
Unlock24.7%6.2%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

8QQ Income Statement

People Also Watch

14.25
OSCR
-2.86%
52.879
ASTS
-2.47%
15.857
ZETA
-1.20%
51.555
SMR
+1.11%
16.030
IREN
-3.32%

FAQ

What Stock Exchange Does Abcellera Biologics Inc Trade On?

Abcellera Biologics Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Abcellera Biologics Inc?

The stock symbol for Abcellera Biologics Inc is "8QQ."

What Is the Abcellera Biologics Inc Market Cap?

As of today, Abcellera Biologics Inc market cap is 1.25B.

What Is Abcellera Biologics Inc's Earnings Per Share (TTM)?

The Abcellera Biologics Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 8QQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abcellera Biologics Inc Stock Split?

Abcellera Biologics Inc has split 0 times.

What is the current trading status of Abcellera Biologics Inc (8QQ)?

As of 29 Jul 2025, Abcellera Biologics Inc (8QQ) is trading at a price of 4.36, with a previous close of 4.24. The stock has fluctuated within a day range of 4.24 to 4.36, while its 52-week range spans from 1.72 to 4.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.